Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A highly potent artificial transcription factor.

Dusan Stanojevic1, Richard A Young

  • 1Crosslink Genetics Corporation, One Kendall Square, Building 600, PMB 255, Cambridge, MA 02139, USA. ds@crosslinkgenetics.com

Biochemistry
|June 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Analysis of Common Questions and Concerns of Older Adults with Multiple Chronic Conditions.

Journal of the American Board of Family Medicine : JABFM·2026
Same author

Active RNA synthesis patterns nuclear condensates.

Cell systems·2026
Same author

Family Physicians' Views of Who They Are Accountable To and Current Quality Metrics.

JAMA network open·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Protein codes and mobility together shape cellular function and disease.

Trends in biochemical sciences·2025
Same author

Emotion in Career-Related Transitions of Young Adult Immigrants: A Contextual Action Theory Perspective.

Journal of career development·2025

Researchers developed a synthetic molecule that acts as a potent artificial transcription factor (ATF). This novel molecular tool enables targeted gene regulation and shows promise for developing new gene-targeting pharmaceuticals.

Area of Science:

  • Molecular Biology
  • Synthetic Chemistry
  • Gene Regulation

Background:

  • Transcription factors are crucial for targeted gene regulation.
  • Designing synthetic analogues offers novel molecular tools.
  • Existing methods for gene regulation can be limited.

Purpose of the Study:

  • To engineer a synthetic molecule functioning as a potent artificial transcription factor (ATF).
  • To evaluate the in vitro and intracellular efficacy of the designed ATF.
  • To explore the potential of ATFs for gene-targeting therapies.

Main Methods:

  • Synthesized a nonpeptidic artificial transcription factor (ATF) comprising a DNA-binding domain, linker, and peptide.
  • Compared ATF activity with natural transcription factors using in vitro assays.

Related Experiment Videos

  • Assessed ATF-mediated transcriptional activation in tissue culture cells.

    • Main Results:

    • The synthetic ATF successfully initiated RNA transcription at the correct site in vitro.
    • ATF's transcriptional activation potency matched or exceeded natural activators like GAL4-VP16.
    • Demonstrated significant ATF-driven transcription activation within tissue culture cells.

    Conclusions:

    • Engineered artificial transcription factors (ATFs) are potent molecular tools for targeted gene regulation.
    • ATFs exhibit strong biological activity both in vitro and in cell-based systems.
    • The synthetic ATF design holds potential for developing novel pharmaceuticals for disease treatment.